引用次数
引用: 3,981
H-指数: 26
I10-指数 : 36
出版物: 86
Nacimiento de la Sociedad de Spanish Researchers in The United Kingdom
Lorenzo Melchor Fernández
Revista De Occidente ( 380) 126 -128
2013
Caracterización de los tumores de mama familiares mediante citogenética molecular
Lorenzo Melchor Fernández
Universidad Autónoma de Madrid
2008
Ciencia fuera de España: razones para irse y consecuencias para el sistema. Perspectivas y consejos
Lorenzo Melchor Fernández
Reflexiones sobre la ciencia en España: cómo salir del atolladero, 2016, ISBN 978-84-7209-680-6, págs. 99-136 99 -136
2016
Ciencia entre fronteras: la "diplomacia científica" y España a inicios del siglo XX
Lorenzo Melchor Fernández , Francisco A. González Redondo
Ciencia y técnica en la universidad: trabajos de historia de las ciencias y de las técnicas, Vol. 1, 2018 (Volumen I), ISBN 978-84-16978-80-9, págs. 339-350 339 -350
2018
A Predictor Based on the Somatic Genomic Changes of the BRCA1/BRCA2 Breast Cancer Tumors Identifies the Non-BRCA1/BRCA2 Tumors with BRCA1 Promoter Hypermethylation
Ramon Diaz-Uriarte , Emiliano Honrado , Juan Cruz Cigudosa , Manel Esteller
Clinical Cancer Research 11 ( 3) 1146 -1153
71
2005
The Mutational Landscape of Relapse in High Risk Myeloma Is Significantly Impacted By the Depth of Response but Not Maintenance Lenalidomide
Mark T Drayson , Amy L Sherborne , Charlotte Pawlyn , Charlotte Pawlyn
Blood 130 396 -396
1
2017
The 'Matters' of Science Diplomacy: Transversal Analysis of the S4D4C Case Studies
Tim Flink , Mitchell Young , Charlotte Rungius , Ewert J. Aukes
S4D4C
2020
Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.
Giusy Tornillo , Kirsty R. Greenow , Lorenzo Melchor , Matthew J. Smalley
Disease Models & Mechanisms 14 ( 5)
2021
What Is a Science Diplomat
Lorenzo Melchor
The Hague Journal of Diplomacy 15 ( 3) 409 -423
2020
Spatiotemporal Analysis of Intraclonal Heterogeneity in Multiple Myeloma: Unravelling the Impact of Treatment and the Propagating Capacity of Subclones Using Whole Exome Sequencing
Lorenzo Melchor , John R Jones , Oleg Lenive , Erich Allen Peterson
Blood 126 ( 23) 371 -371
4
2015
Genomic analysis of the 8p11-12 amplicon in familial breast cancer.
Lorenzo Melchor , Maria J Garcia , Emiliano Honrado , Jessica CM Pole
International Journal of Cancer 120 ( 3) 714 -717
26
2007
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.
Brian A. Walker , Christopher P. Wardell , Lorenzo Melchor , Sanna Hulkki
Blood 120 ( 5) 1077 -1086
194
2012
Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma
Martin F. Kaiser , David C. Johnson , Ping Wu , Brian A. Walker
Blood 122 ( 2) 219 -226
178
2013
Biology and Treatment of Myeloma
Annamaria Brioli , Lorenzo Melchor , Brian A. Walker , Faith E. Davies
Clinical Lymphoma, Myeloma & Leukemia 14
14
2014
The Impact of Maintenance Lenalidomide and Depth of Response on the Mutational Status of the Myeloma Clone from Presentation to Relapse
John Jones , Niels Weinhold , Shweta Chavan , Charlotte Pawlyn
Clinical Lymphoma, Myeloma & Leukemia 17 ( 1)
2017
Mutational Patterns and Copy Number Changes at Diagnosis Are a Powerful Tool to Predict Outcome: Result of the Sequencing Study of 463 Newly Diagnosed Myeloma Trial Patients
Eileen M Boyle , Brian A Walker , Christopher P Wardell , Alexander Murison
Blood 124 ( 21) 637 -637
2
2014
The Extent of Intra-Clonal Genetic Diversity within the Myeloma Clone Is a Predictive Biomarker of Progression and Outcome after Treatment
Lorenzo Melchor , Alexander Murison , Eileen M Boyle , Christopher P Wardell
Blood 124 ( 21) 640 -640
1
2014
Myeloma XI Trial for Newly Diagnosed Multiple Myeloma (NDMM); A Report of Second Primary Malignancy (SPM) Rates and the Importance of Review of Reported Cases
John R Jones , David A Cairns , Rachel Sigsworth , Corinne Collett
Blood 126 ( 23) 1847 -1847
2
2015
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients
John R. Jones , Niels Weinhold , Cody Ashby , Brian A. Walker
Haematologica 104 ( 7) 1440 -1450
21
2019
The impact of intra-clonal heterogeneity on the treatment of multiple myeloma.
Annamaria Brioli , Lorenzo Melchor , Michele Cavo , Gareth J. Morgan
British Journal of Haematology 165 ( 4) 441 -454
128
2014